InsidersTradesSigma
Follow the Semnur Pharmaceuticals, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €191.1m. The latest transaction was reported on 25 September 2025 (Cession). Among the most active insiders: Scilex Holding Co. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Semnur Pharmaceuticals, Inc. 是一家专注于开发疼痛和神经系统疾病治疗方法的公司。它在纳斯达克上市，股票代码为XNAS。